The extracellular matrix (ECM) is made of three main categories of molecules: structural proteins like collagen and elastin, gel-like sugar chains called glycosaminoglycans and proteoglycans, and adhesive glycoproteins like fibronectin and laminin. Together, these components form the scaffolding that surrounds and supports every cell in your body. The exact mix varies dramatically from tissue to tissue, which is why bone feels nothing like skin, and cartilage feels nothing like a tendon.
Collagen: The Most Abundant Protein
Collagen is the dominant structural protein in the ECM and the most abundant protein in the human body overall. It forms long, rope-like fibrils that give tissues their tensile strength, meaning their ability to resist being pulled apart. This fibril arrangement lets connective tissues withstand tension, shear, and pressure. Beyond mechanical support, collagen also influences how cells attach to their surroundings and how they migrate from one location to another.
There are many types of collagen, and each serves a different role. Types I, II, III, V, and XI form fibrils in the main body of the ECM. Type IV collagen is different: instead of forming fibrils, it assembles into sheet-like networks that are the backbone of basement membranes, the thin mats of ECM that line organs, blood vessels, and skin. Type VII collagen forms anchoring fibrils that physically connect basement membranes to the deeper connective tissue below them.
Elastin: The Recoil Factor
Where collagen resists stretching, elastin allows it. Elastin is built from individual protein subunits that are cross-linked together and wrapped in an outer layer of supportive microfibrils. This architecture lets tissues snap back to their original shape after being stretched. Your skin, arteries, and lungs all rely heavily on elastin to function normally.
In some tissues, elastin makes up only a small fraction of the dry weight. Tendons, for example, contain roughly 2% elastin by dry weight. Even at that low concentration, it plays a critical role: it allows the crimped, wavy structure of tendon fibers to stretch under load and then spring back. Without it, tendons would lose the elastic quality that makes normal movement possible.
Glycosaminoglycans and Proteoglycans
If collagen and elastin are the cables and springs of the ECM, glycosaminoglycans (GAGs) are the gel that fills the spaces between them. GAGs are long chains of sugar molecules that carry a strong negative electrical charge. That charge attracts water, which makes GAGs swell into a hydrated gel. This gel resists compression, essentially acting like a shock absorber. When you stand up and your knee cartilage absorbs the impact, it’s largely the GAG-rich gel doing the work.
The four main families of GAGs are heparan sulfate, chondroitin sulfate, keratan sulfate, and hyaluronic acid. Most GAGs don’t float freely in the matrix. Instead, they’re attached to a central protein, forming larger molecules called proteoglycans. In cartilage, the most important proteoglycan is aggrecan, which bristles with chondroitin sulfate and keratan sulfate chains. Aggrecan’s negative charges draw in so much water that cartilage develops internal swelling pressure, giving it the firmness and bounce it needs to cushion joints.
Hyaluronic acid is the exception among GAGs because it isn’t attached to a core protein. It exists as a free, enormously long chain and is found at concentrations up to about 1 mg/ml in tissues like skin and in the temporary matrices that form during wound healing. By modulating how fluid moves through the matrix, hyaluronic acid changes the tissue’s stiffness and resistance to compression. Its effects come primarily from altering the physical properties of the fluid phase rather than changing the structure of collagen fibers themselves.
Adhesive Glycoproteins
Cells need a way to grab onto the matrix around them, and adhesive glycoproteins provide the handholds. The two most important are fibronectin and laminin. These proteins do double duty: they help establish the physical architecture of the matrix while also connecting to the surface of cells and influencing cell behavior.
Fibronectin is found throughout the main body of connective tissue and also in the layer that attaches basement membranes to deeper tissue. Laminin is concentrated in basement membranes, where it self-assembles into its own network alongside type IV collagen. Two smaller proteins, nidogen and perlecan, link the collagen and laminin networks together into a single, stable sheet. Every basement membrane in the body, whether under your skin, around your blood vessels, or lining your intestines, contains this same core set of four molecules.
How Cells Connect to the Matrix
Cells don’t just sit passively inside the ECM. They physically grip it using surface receptors called integrins, which span the cell membrane. On the outside, integrins bind to ECM proteins like collagen, fibronectin, and laminin. On the inside, they connect to the cell’s internal skeleton through a chain of linking proteins. This creates a continuous mechanical connection from the matrix outside the cell all the way to the structural framework inside it.
This connection isn’t just structural. It’s also a communication channel. When the matrix is stretched or compressed, integrins transmit that mechanical force into the cell, where it triggers biological responses. Cells can sense how stiff or soft their surroundings are and change their behavior accordingly, growing, moving, or even dying based on the mechanical signals they receive through their integrin connections. This force-sensing system helps explain why cells behave so differently in rigid bone versus soft brain tissue, even when they carry the same DNA.
How Composition Varies by Tissue
The ECM isn’t one material. It’s a whole family of materials, and each tissue tunes its recipe to match its mechanical needs. Cartilage is built around a collagen network (primarily type II) for tensile strength and massive amounts of aggrecan for compression resistance. Bone starts with a collagen-rich matrix similar to cartilage but then mineralizes it with calcium and phosphate crystals, converting a flexible scaffold into something rigid enough to bear your body weight. The conversion of cartilage into bone during development requires coordinated changes across multiple ECM components.
Skin relies on a mix of type I and type III collagen for strength and a relatively high concentration of elastin and hyaluronic acid for stretch and hydration. Tendons are almost entirely type I collagen, organized into parallel bundles that resist pulling forces in one direction. Blood vessel walls are elastin-rich, allowing them to expand and contract with every heartbeat. The common thread is that every tissue’s function can be traced back to its specific combination of ECM ingredients.
The Matrix Is Constantly Remodeled
The ECM is not a fixed structure. Your body continuously breaks it down and rebuilds it using specialized enzymes called matrix metalloproteinases (MMPs). These enzymes chop up collagen, elastin, and other matrix components so they can be replaced with fresh material. Immune cells can also clear old collagen by engulfing it and breaking it down internally. Other enzymes trim sugar chains on proteoglycans, releasing growth factors and signaling molecules that were stored in the matrix.
This constant turnover is essential for normal development. Organ formation in the intestines, lungs, and mammary glands all depend on precisely timed ECM remodeling. The matrix also acts as a storage depot for growth factors and signaling molecules. These are bound to glycoproteins within the ECM and released when enzymes cut the proteins loose, giving the body a way to deliver chemical signals exactly where and when they’re needed.
When remodeling goes wrong, the consequences can be serious. Excessive ECM buildup leads to fibrosis, where organs become stiff and scarred. In cancer, tumor cells hijack matrix remodeling to create an environment that supports their growth and spread. Tumors that produce high levels of MMPs tend to be more aggressive and more likely to recur, while tumors with high levels of natural protease inhibitors carry a better prognosis.